259 related articles for article (PubMed ID: 37070985)
1. Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline.
Wang Y; Su J; Zhou Z; Yang J; Liu W; Zhang Y; Zhang P; Guo T; Li G
Microbiol Spectr; 2023 Jun; 11(3):e0470222. PubMed ID: 37070985
[TBL] [Abstract][Full Text] [Related]
2. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
[TBL] [Abstract][Full Text] [Related]
3. Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens.
Wang W; Zhu X; Luo H; Wang Z; Hong A; Zeng J; Li L; Wang D; Deng X; Zhao X
Microbiol Spectr; 2023 Feb; 11(1):e0379022. PubMed ID: 36533939
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
5. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
Liu Y; Li R; Xiao X; Wang Z
Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon R; Idowu T; Zhanel GG; Schweizer F
Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
[TBL] [Abstract][Full Text] [Related]
10. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
[TBL] [Abstract][Full Text] [Related]
11. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
[TBL] [Abstract][Full Text] [Related]
12. Silver enhances antibiotic activity against gram-negative bacteria.
Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
[TBL] [Abstract][Full Text] [Related]
13. Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.
Poulakou G; Giamarellou H
Expert Opin Investig Drugs; 2008 May; 17(5):749-71. PubMed ID: 18447600
[TBL] [Abstract][Full Text] [Related]
14. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
[TBL] [Abstract][Full Text] [Related]
15. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
16. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
Elife; 2022 Jan; 11():. PubMed ID: 35025730
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for infections caused by multidrug-resistant Gram-negative bacteria: a guide to good clinical practice.
Delroba K; Alaei M; Khalili H
Future Microbiol; 2023 Mar; 18():287-294. PubMed ID: 37140271
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
[TBL] [Abstract][Full Text] [Related]
19. Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
Pybus CA; Felder-Scott C; Obuekwe V; Greenberg DE
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199383
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
